CD8A and infection: In particular, TSKb20, a peptide predicted to bind mouse MHC class I molecule H-2Kb, has demonstrated a high level of immunodominance in the murine infection model, with specific cells reaching up to 30% of the circulating CD8+ T lymphocytes (158, 159).